Medigen Vaccine Biologics Corp Collaborates with Substipharm Biologics Expanding ENVACGEN® Enterovirus A71 Vaccine Market in Southeast Asia
- Written by PR Newswire Asia - Asian Spectator
TAIPEI and GENEVA, Jan. 9, 2025 /PRNewswire/ -- Medigen Vaccine Biologics Corp (MVC) has signed a regional distribution agreement with the pharmaceutical company Substipharm Biologics to expand the market reach of enterovirus vaccine products in Southeast Asia. The two companies have finalized an exclusive distribution agreement for ENVACGEN® E...
